|
|
Polwarth Building, Foresterhill
Aberdeen, AB25 2ZD United Kingdom
phone:(44) (0) 1224 555889
fax:(44) (0) 1224 555844
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.haptogen.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Products in the areas of anti-infectives, obesity and oncology. |
|
| Management |
| Jim Reid, Chief Executive Officer; Andy Porter, Chief Scientific Officer; Fiona Adair, Chief Business Officer and Director |
| |
|
|
| |
|
| Keywords |
| biotechnology, haptens, small, molecules, epitope, but, antibody, therapeutic, diagnostic, separation, anti-infectives, obesity, oncology |
|
|
|
| Description |
|
Haptogen is focused on the development of haptens, small molecules which can act as an epitope but, are incapable of eliciting an antibody response alone, to generate novel and effective therapeutic, diagnostic and separation products, in a number of clinical areas including anti-infectives, obesity and oncology. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members